Prescription drug · ANDA
Oxycodone and Acetaminophen NDC 63187-721
Oxycodone hydrochloride 10 mg/1; Acetaminophen 325 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-721-15 | 63187072115 | 15 TABLET in 1 BOTTLE (63187-721-15)Marketed from Jun 1, 2016 | |
| 63187-721-20 | 63187072120 | 20 TABLET in 1 BOTTLE (63187-721-20)Marketed from Jun 1, 2016 | |
| 63187-721-30 | 63187072130 | 30 TABLET in 1 BOTTLE (63187-721-30)Marketed from Jun 1, 2016 | |
| 63187-721-60 | 63187072160 | 60 TABLET in 1 BOTTLE (63187-721-60)Marketed from Jun 1, 2016 | |
| 63187-721-90 | 63187072190 | 90 TABLET in 1 BOTTLE (63187-721-90)Marketed from May 30, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oxycodone and Acetaminophen
- Generic name (nonproprietary)
- oxycodone and acetaminophen
- Active ingredients
- Oxycodone hydrochloride — 10 mg/1Acetaminophen — 325 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040778
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Full Opioid Agonists (Mechanism)
- Identifiers
- Product ID 63187-721_b6da114d-fc88-4f72-9055-a963b4625f25SPL ID b6da114d-fc88-4f72-9055-a963b4625f25SPL set ID 6253b3ae-bb52-4532-8d1f-756c0b1577c7RxCUI 1049214UNII C1ENJ2TE6C, 362O9ITL9D
- Pharmacologic class
- Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187072115followed by a unit qualifier and the quantityPackage 63187-0721-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Oxycodone and Acetaminophen Tablets, USP are indicated for the relief of moderate to moderately severe pain.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040778
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Oxycodone and Acetaminophen | Acetaminophen 325 mg/1; Oxycodone hydrochloride 10 mg/1 | TabletOral | AvPAK | 50268-646 |
| Oxycodone and Acetaminophen | Oxycodone hydrochloride 7.5 mg/1; Acetaminophen 325 mg/1 | TabletOral | AvPAK | 50268-645 |
| Oxycodone and Acetaminophen | Oxycodone hydrochloride 10 mg/1; Acetaminophen 325 mg/1 | TabletOral | Amneal Pharmaceuticals of New York LLC | 53746-204 |
| Oxycodone and Acetaminophen | Oxycodone hydrochloride 7.5 mg/1; Acetaminophen 325 mg/1 | TabletOral | Amneal Pharmaceuticals LLC | 65162-207 |